Contexium

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 24 Sep 2026. The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis wit…

Opportunity overview

Project name
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN)...

Frequently asked questions

What is Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)?

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 24 Sep 2026. The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis wit…

Who is funding Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)?

Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)?

The application deadline is 24 Sep 2026 00:00 (UTC).

Where will the Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) project take place?

The project location(s) are: United States.

How can I apply for Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.